泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTNP 泰坦制药

未开盘 05-06 16:00:00 EDT

3.83

-0.01

-0.26%

盘后3.83

+0.000.00%

17:27 EDT

最高3.83	最低3.60	成交量2,479
今开3.74	昨收3.84	日振幅5.99%
总市值350.15万	流通市值219.63万	总股本91.42万
成交额9,270	换手率0.43%	流通股本57.34万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTNP","market":"US","secType":"STK","nameCN":"泰坦制药","latestPrice":3.83,"timestamp":1746561600000,"preClose":3.84,"halted":0,"volume":2479,"hourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"17:27 EDT","volume":2,"amount":7.04,"timestamp":1746566876167},"delay":0,"floatShares":573434,"shares":914234,"eps":-5.234705,"marketStatus":"未开盘","change":-0.01,"latestTime":"05-06 16:00:00 EDT","open":3.74,"high":3.83,"low":3.6,"amount":9269.730154,"amplitude":0.059896,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.234705,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.84,"preHourTrading":{"tag":"盘前","latestPrice":3.6,"preClose":3.78,"latestTime":"08:00 EDT","volume":1,"amount":3.6,"timestamp":1746532801148},"postHourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"17:27 EDT","volume":2,"amount":7.04,"timestamp":1746566876167},"volumeRatio":0.126192,"impliedVol":2.3693,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TTNP","defaultTab":"news","newsList":[{"id":"2533650304","title":"泰坦制药盘中异动 大幅下跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650304?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:25","pubTimestamp":1746545135,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时25分，泰坦制药股票出现异动，股价大幅下跌6.25%。截至发稿，该股报3.60美元/股，成交量1307股，换手率0.14%，振幅2.34%。泰坦制药股票所在的生物技术行业中，整体跌幅为4.19%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506232535aa2c84a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506232535aa2c84a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2532826262","title":"泰坦制药盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532826262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532826262?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:43","pubTimestamp":1746200603,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时43分，泰坦制药股票出现波动，股价大幅跳水5.01%。截至发稿，该股报3.66美元/股，成交量2437股，换手率0.27%，振幅3.60%。泰坦制药股票所在的生物技术行业中，整体涨幅为1.22%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502234323a6d1330e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502234323a6d1330e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2530115605","title":"泰坦制药盘中异动 早盘股价大涨8.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530115605?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:25","pubTimestamp":1745594733,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日23时25分，泰坦制药股票出现异动，股价快速上涨8.44%。截至发稿，该股报4.11美元/股，成交量983股，换手率0.11%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.21%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523253397453124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042523253397453124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2517169084","title":"泰坦制药盘中异动 股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517169084?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271907,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，泰坦制药股票出现异动，股价急速下挫5.54%。截至发稿，该股报3.75美元/股，成交量7577股，换手率0.83%，振幅8.19%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.53%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223827a2629246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223827a2629246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2516677528","title":"泰坦制药盘中异动 早盘大幅上涨8.21%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677528?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:48","pubTimestamp":1741099709,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时48分，泰坦制药股票出现异动，股价急速上涨8.21%。截至发稿，该股报4.35美元/股，成交量2124股，换手率0.23%，振幅1.99%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.56%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224830a25f0a40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224830a25f0a40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2516372930","title":"泰坦制药盘中异动 临近午盘股价大涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372930?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:15","pubTimestamp":1740762939,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时15分，泰坦制药股票出现波动，股价急速上涨6.40%。截至发稿，该股报4.17美元/股，成交量2449股，换手率0.27%，振幅3.57%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.56%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030101153996343f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030101153996343f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2514893703","title":"泰坦制药盘中异动 早盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514893703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514893703?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:05","pubTimestamp":1740668728,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时05分，泰坦制药股票出现波动，股价大幅跳水5.43%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.75%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230528abdf77c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230528abdf77c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2514859846","title":"泰坦制药盘中异动 早盘股价大涨6.50%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859846?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:37","pubTimestamp":1740580645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时37分，泰坦制药股票出现波动，股价快速上涨6.50%。截至发稿，该股报3.93美元/股，成交量1.2444万股，换手率1.36%，振幅5.96%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.40%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622372696315049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622372696315049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2514701599","title":"泰坦制药盘中异动 早盘股价大跌5.33%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514701599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514701599?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:13","pubTimestamp":1740496423,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时13分，泰坦制药股票出现异动，股价快速下挫5.33%。截至发稿，该股报3.28美元/股，成交量4448股，换手率0.49%，振幅5.20%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.80%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231343a2539197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231343a2539197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2513172730","title":"泰坦制药盘中异动 股价大涨5.87%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513172730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513172730?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:36","pubTimestamp":1740407761,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时36分，泰坦制药股票出现异动，股价急速拉升5.87%。截至发稿，该股报3.89美元/股，成交量2680股，换手率0.29%，振幅6.96%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.23%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223601a2521584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223601a2521584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2509742756","title":"泰坦制药盘中异动 股价大跌5.28%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509742756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509742756?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:44","pubTimestamp":1738939470,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时44分，泰坦制药股票出现波动，股价快速下挫5.28%。截至发稿，该股报3.45美元/股，成交量2680股，换手率0.29%，振幅2.47%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.17%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224430abc62da2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224430abc62da2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2509280010","title":"泰坦制药盘中异动 早盘股价大涨7.69%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280010?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:03","pubTimestamp":1738767811,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时03分，泰坦制药股票出现波动，股价大幅上涨7.69%。截至发稿，该股报3.50美元/股，成交量8219股，换手率0.90%，振幅0.62%。泰坦制药股票所在的生物技术行业中，整体涨幅为1.51%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230331abc384c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230331abc384c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2508114906","title":"泰坦制药盘中异动 急速上涨7.69%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508114906?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593359,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，泰坦制药股票出现异动，股价大幅拉升7.69%。截至发稿，该股报3.50美元/股，成交量1914股，换手率0.21%，振幅1.23%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.36%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223559a2380ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223559a2380ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2508990799","title":"泰坦制药盘中异动 临近收盘股价大跌6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508990799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508990799?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:45","pubTimestamp":1738356319,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时45分，泰坦制药股票出现波动，股价大幅下挫6.14%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.56%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104451998778917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104451998778917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2507622279","title":"泰坦制药盘中异动 早盘大幅上涨7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507622279?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:41","pubTimestamp":1738248091,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时41分，泰坦制药股票出现波动，股价快速上涨7.47%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.08%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302241329876b2fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302241329876b2fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2507634076","title":"泰坦制药盘中异动 早盘急速上涨6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507634076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507634076?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:00","pubTimestamp":1738162804,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时00分，泰坦制药股票出现异动，股价急速上涨6.93%。截至发稿，该股报3.55美元/股，成交量868股，换手率0.09%，振幅7.23%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.13%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129230004abbc60b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129230004abbc60b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2507546166","title":"泰坦制药盘中异动 急速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507546166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507546166?lang=zh_cn&edition=full","pubTime":"2025-01-29 01:02","pubTimestamp":1738083721,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日01时02分，泰坦制药股票出现异动，股价快速跳水5.14%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.17%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129010201a2328d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129010201a2328d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2505040775","title":"泰坦制药盘中异动 下午盘大幅拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505040775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505040775?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:25","pubTimestamp":1737660341,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时25分，泰坦制药股票出现波动，股价快速上涨5.29%。泰坦制药股票所在的生物技术行业中，整体涨幅为1.17%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240325429870ee61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240325429870ee61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2504162583","title":"泰坦制药盘中异动 早盘股价大涨5.09%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504162583?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:46","pubTimestamp":1737125169,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时46分，泰坦制药股票出现异动，股价急速拉升5.09%。截至发稿，该股报3.31美元/股，成交量291股，换手率0.03%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.40%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224610abaeb418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224610abaeb418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.titanpharm.com","stockEarnings":[{"period":"1week","weight":0.0669},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0728},{"period":"6month","weight":-0.0837},{"period":"1year","weight":-0.4433},{"period":"ytd","weight":0.1748}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.1059},{"period":"3month","weight":-0.0752},{"period":"6month","weight":-0.0618},{"period":"1year","weight":0.0818},{"period":"ytd","weight":-0.0465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Titan Pharmaceuticals, Inc.于1992年2月根据特拉华州法律成立。该公司是一家制药公司。该公司专注于利用专有的长期给药平台ProNeura开发治疗药物，用于治疗特定的慢性疾病，其中稳态给药有可能提供疗效。ProNeura由一种由乙烯-醋酸乙烯酯（“EVA”）和一种药物混合物制成的小型固体植入物组成。产生的产物是一种固体基质，设计用于在简短的门诊程序中进行皮下给药，并在治疗期结束时以类似方式移除。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.010618},{"month":2,"riseRate":0.6,"avgChangeRate":0.057895},{"month":3,"riseRate":0.3,"avgChangeRate":-0.031972},{"month":4,"riseRate":0.3,"avgChangeRate":-0.043803},{"month":5,"riseRate":0.4,"avgChangeRate":-0.068444},{"month":6,"riseRate":0.555556,"avgChangeRate":0.008509},{"month":7,"riseRate":0.222222,"avgChangeRate":0.086632},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.134895},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.189655},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.05513},{"month":11,"riseRate":0.3,"avgChangeRate":-0.064476},{"month":12,"riseRate":0.2,"avgChangeRate":-0.096803}],"exchange":"NASDAQ","name":"泰坦制药","nameEN":"Titan Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰坦制药,TTNP,泰坦制药股票,泰坦制药股票老虎,泰坦制药股票老虎国际,泰坦制药行情,泰坦制药股票行情,泰坦制药股价,泰坦制药股市,泰坦制药股票价格,泰坦制药股票交易,泰坦制药股票购买,泰坦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}